Bladex (BLX) Q1 2026 earnings review
Record Volume Masks EPS Contraction
Bladex expanded its credit portfolio to a record $13.5 billion (+13% YoY) and grew Net Profit by 9% to $56.4 million. However, the top-line recovery didn't reach the per-share bottom line. EPS fell 7% YoY to $1.31, dragged down by AT1 coupon distributions and a compressing Net Interest Margin (2.34%). While the bank is successfully shifting toward fee-based income (+24% YoY) and cheap deposit funding, the margin pressure from lower rates and a noticeable uptick in Stage 2 loans warrant caution.
🐂 Bull Case
Deposits surged 25% YoY to $7.3 billion, now representing 63% of the bank's funding sources (up 600bps YoY). This fundamentally lowers the cost of capital and reliance on wholesale debt.
The transition to a transactional trade model is working. Fees and non-interest income jumped 24% YoY, driven by strong letter of credit volumes and loan syndication.
🐻 Bear Case
Despite higher absolute profits, the recent AT1 capital issuance is diluting common shareholder returns, pushing Q1 EPS down 13% sequentially and 7% YoY.
Stage 2 loans increased to 2.2% of the portfolio. While overall non-performing loans remain low, this migration signals early stress in the macro environment.
⚖️ Verdict: ⚪
Neutral. Management is executing flawlessly on volume growth and funding optimization, but macroeconomic rate cuts and the new capital structure are capping immediate shareholder upside.
Key Themes
Deposit Base Revolution
Deposits have become Bladex's most powerful growth engine. Reaching an all-time high of $7.31 billion (+25% YoY), deposits now constitute 63% of total funding. This structural shift provides a cheaper, stickier funding base that helps insulate the bank against aggressive rate cuts and reduces dependence on volatile interbank markets.
Fee Income Validates Strategy
Management's vision to transition into a transactional trade banking platform is bearing fruit. Fees and commissions rose 24% YoY to $13.1 million. The growth stems from off-balance sheet letters of credit and a highly active loan syndication desk, proving Bladex can monetize its structuring capabilities without tying up capital.
NIM Compression Materializing
The macro environment is biting into yields. Net Interest Margin (NIM) fell to 2.34%, down 2bps YoY and 5bps sequentially. Management explicitly cited lower base rates and heightened market liquidity driving competitive pricing. As central banks continue to cut rates, defending this margin will be Bladex's primary challenge in 2026.
Asset Quality: Narrative vs. Data
While the press release touts 'healthy asset quality', the data shows a different underlying current. Stage 2 exposures migrated upward to 2.2% of the portfolio (up from 1.5% at the end of 2025). Although Stage 3 loans remain flat at 0.3%, the doubling of Stage 2 indicates proactive defensive posturing against regional economic deterioration—particularly in markets like Brazil and Colombia mentioned in prior calls.
Introduction of the Commercial Bond Portfolio
Bladex innovated its capital deployment by creating a 'Commercial Bond Portfolio' in Q1, reaching an outstanding balance of $234 million. This provides a new, selective mechanism to deploy excess liquidity within their existing credit framework, helping offset margin compression in traditional lending.
AT1 Issuance Drag on Returns
The September 2025 AT1 capital issuance fortified the balance sheet (Tier 1 ratio is a massive 17.9%), but it is severely taxing equity returns. Return on Average Equity (ROE) dropped sharply by 197bps YoY to 13.5%. Even the adjusted ROE (excluding other equity instruments) fell 121bps YoY to 14.2%. The cost of safety is currently limiting EPS growth.
Other KPIs
Improving. The ratio fell 437bps sequentially (from 30.9% in 25Q4) and 45bps YoY. Total revenues grew 7% YoY, effectively outpacing the 5% increase in operating expenses tied to the rollout of new IT trade platforms.
Accelerating. Up 283bps YoY from 15.1% in 25Q1, providing a massive buffer above regulatory minimums. This excess capital affords management immense flexibility to either absorb macroeconomic shocks or aggressively chase syndication and loan growth.
Guidance
Stable. Q1 came in at 2.34%, representing a slight deceleration from 2.39% in 25Q4, but tracking cleanly ahead of the annual ~2.3% guidance. If rate cuts accelerate, achieving this floor will require flawless execution on deposit pricing.
Stable. The commercial portfolio grew exactly 13% YoY in Q1 to $12.05 billion. The bank is tracking perfectly against its full-year volume target, signaling that demand remains robust despite rate volatility.
Stable. Adjusted ROE for Q1 printed at 14.2%. The bank is operating at the lower bound of its guidance. Given the fixed AT1 coupon costs, any further NIM compression risks pushing ROE below the 14% threshold.
Accelerating. Q1 efficiency came in at a stellar 26.5%. If the bank maintains this expense discipline, it is highly likely to beat the 28% full-year target, even with ongoing tech investments.
Key Questions
Stage 2 Migration Drivers
Stage 2 exposures increased to 2.2% of the portfolio. What specific geographies or sectors drove this migration, and is it related to the localized bankruptcies in Brazil or fiscal concerns in Colombia flagged last quarter?
Commercial Bond Portfolio Strategy
You deployed $234 million into a new Commercial Bond Portfolio. What is the target size for this portfolio by year-end, and how does its yield compare to the traditional commercial loan book?
Defending the NIM Floor
With Q1 NIM at 2.34% and global rate cuts expected to continue, how much further can you drive down deposit costs to defend the ~2.3% full-year margin target before risking deposit flight?